Loading
Life sciences · Journal article
Frontiers in Endocrinology · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Body mass index (BMI) may fail to capture clinically relevant heterogeneity in adiposity-related diabetes risk, particularly among Asian adults who are not classified as obese. We investigated whether abdominal obesity and fatty liver identify distinct risks of incident type 2 diabetes mellitus (T2DM) among adults with BMI <25 kg/m 2. Methods This secondary analysis used data from the Japanese NAGALA cohort. A total of 12,940 adults without diabetes at baseline and with BMI <25 kg/m 2 were classified into four phenotypes: neither abdominal obesity nor fatty liver, isolated abdominal obesity, isolated fatty liver, and combined abdominal obesity and fatty liver. Cox proportional hazards models were used to estimate hazard ratios (HRs) for incident T2DM. We additionally assessed adiposity-component burden, multiplicative and additive interaction, sex-specific associations, multiple sensitivity analyses, and incremental 5-year predictive performance. Results During 78,694.5 person-years of follow-up, 201 incident T2DM events occurred. Incidence rates were 1.70, 2.61, 8.20, and 21.37 per 1,000 person-years across the four phenotypes, respectively. In the fully adjusted model, isolated abdominal obesity was not significantly associated with T2DM (HR 1.47, 95% CI 0.66–3.31), whereas isolated fatty liver (HR 3.43, 95% CI 2.41–4.87) and combined abdominal obesity and fatty liver (HR 8.10, 95% CI 4.65–14.12) were strongly associated with higher risk. Risk increased progressively with the number of non-BMI adiposity components (P for trend <0.001). Associations with fatty liver were observed in both sexes, with no clear evidence of effect modification by sex (P for interaction=0.176), and remained robust in sensitivity analyses, including restriction to BMI <23 kg/m 2. Adding abdominal obesity, fatty liver, or the four-level phenotype to a comprehensive clinical model did not clearly improve 5-year predictive performance. Conclusions Among BMI-defined non-obese adults, fatty liver—especially when accompanied by abdominal obesity—identified substantial heterogeneity in incident T2DM risk. These findings highlight the limitations of BMI alone for characterizing adiposity-related metabolic risk, while not establishing incremental predictive utility beyond established clinical risk factors.